177 related articles for article (PubMed ID: 23052840)
1. A potential role of the GRO-α/CXCR2 system in Sjögren's syndrome: regulatory effects of pro-inflammatory cytokines.
Lisi S; Sisto M; Lofrumento DD; D'Amore M; De Lucro R; Ribatti D
Histochem Cell Biol; 2013 Feb; 139(2):371-9. PubMed ID: 23052840
[TBL] [Abstract][Full Text] [Related]
2. New insights into ADAMs regulation of the GRO-α/CXCR2 system: focus on Sjögren's syndrome.
Sisto M; Lisi S
Int Rev Immunol; 2015; 34(6):486-99. PubMed ID: 25386842
[TBL] [Abstract][Full Text] [Related]
3. GRO-α/CXCR2 system and ADAM17 correlated expression in Sjögren's syndrome.
Lisi S; Sisto M; Lofrumento DD; D'Amore M; De Lucro R; Ribatti D
Inflammation; 2013 Jun; 36(3):759-66. PubMed ID: 23389772
[TBL] [Abstract][Full Text] [Related]
4. GRO-α and IL-8 enhance ovarian cancer metastatic potential via the CXCR2-mediated TAK1/NFκB signaling cascade.
Yung MM; Tang HW; Cai PC; Leung TH; Ngu SF; Chan KK; Xu D; Yang H; Ngan HY; Chan DW
Theranostics; 2018; 8(5):1270-1285. PubMed ID: 29507619
[TBL] [Abstract][Full Text] [Related]
5. Pro-inflammatory cytokines enhance ERAD and ATF6α pathway activity in salivary glands of Sjögren's syndrome patients.
Barrera MJ; Aguilera S; Castro I; Cortés J; Bahamondes V; Quest AFG; Molina C; González S; Hermoso M; Urzúa U; Leyton C; González MJ
J Autoimmun; 2016 Dec; 75():68-81. PubMed ID: 27461470
[TBL] [Abstract][Full Text] [Related]
6. Redirecting migration of T cells to chemokine secreted from tumors by genetic modification with CXCR2.
Kershaw MH; Wang G; Westwood JA; Pachynski RK; Tiffany HL; Marincola FM; Wang E; Young HA; Murphy PM; Hwu P
Hum Gene Ther; 2002 Nov; 13(16):1971-80. PubMed ID: 12427307
[TBL] [Abstract][Full Text] [Related]
7. CD40 on salivary gland epithelial cells: high constitutive expression by cultured cells from Sjögren's syndrome patients indicating their intrinsic activation.
Dimitriou ID; Kapsogeorgou EK; Moutsopoulos HM; Manoussakis MN
Clin Exp Immunol; 2002 Feb; 127(2):386-92. PubMed ID: 11876766
[TBL] [Abstract][Full Text] [Related]
8. Salivary gland secretome: a novel tool towards molecular stratification of patients with primary Sjögren's syndrome and non-autoimmune sicca.
Blokland SLM; Hillen MR; van Vliet-Moret FM; Bikker A; de Jager W; Pandit A; Kruize AA; Radstake TRDJ; van Roon JAG
RMD Open; 2019; 5(1):e000772. PubMed ID: 30713719
[TBL] [Abstract][Full Text] [Related]
9. Expression of type III interferons (IFNλs) and their receptor in Sjögren's syndrome.
Apostolou E; Kapsogeorgou EK; Konsta OD; Giotakis I; Saridaki MI; Andreakos E; Tzioufas AG
Clin Exp Immunol; 2016 Dec; 186(3):304-312. PubMed ID: 27613139
[TBL] [Abstract][Full Text] [Related]
10. Sjögren's syndrome pathological neovascularization is regulated by VEGF-A-stimulated TACE-dependent crosstalk between VEGFR2 and NF-κB.
Sisto M; Lisi S; Lofrumento DD; D'Amore M; Frassanito MA; Ribatti D
Genes Immun; 2012 Jul; 13(5):411-20. PubMed ID: 22513453
[TBL] [Abstract][Full Text] [Related]
11. Pro-inflammatory role of Anti-Ro/SSA autoantibodies through the activation of Furin-TACE-amphiregulin axis.
Lisi S; Sisto M; Lofrumento DD; Cucci L; Frassanito MA; Mitolo V; D'Amore M
J Autoimmun; 2010 Sep; 35(2):160-70. PubMed ID: 20673622
[TBL] [Abstract][Full Text] [Related]
12. A combination of in vitro techniques for efficient discovery of functional monoclonal antibodies against human CXC chemokine receptor-2 (CXCR2).
Boshuizen RS; Marsden C; Turkstra J; Rossant CJ; Slootstra J; Copley C; Schwamborn K
MAbs; 2014; 6(6):1415-24. PubMed ID: 25484047
[TBL] [Abstract][Full Text] [Related]
13. Salivary mucins induce a Toll-like receptor 4-mediated pro-inflammatory response in human submandibular salivary cells: are mucins involved in Sjögren's syndrome?
Barrera MJ; Aguilera S; Veerman E; Quest AF; Díaz-Jiménez D; Urzúa U; Cortés J; González S; Castro I; Molina C; Bahamondes V; Leyton C; Hermoso MA; González MJ
Rheumatology (Oxford); 2015 Aug; 54(8):1518-27. PubMed ID: 25802401
[TBL] [Abstract][Full Text] [Related]
14. GRO-alpha and CXCR2 in the human fetal brain and multiple sclerosis lesions.
Filipovic R; Jakovcevski I; Zecevic N
Dev Neurosci; 2003; 25(2-4):279-90. PubMed ID: 12966224
[TBL] [Abstract][Full Text] [Related]
15. Sirolimus diminishes the expression of GRO-α (CXCL-1) /CXCR2 axis in human keratinocytes and cutaneous squamous cell carcinoma cells.
Schaper-Gerhardt K; Hansel A; Walter A; Grimmelmann I; Gutzmer R
J Dermatol Sci; 2021 Oct; 104(1):30-38. PubMed ID: 34479772
[TBL] [Abstract][Full Text] [Related]
16. Expression of pro-inflammatory TACE-TNF-α-amphiregulin axis in Sjögren's syndrome salivary glands.
Sisto M; Lisi S; Lofrumento DD; Ingravallo G; Mitolo V; D'Amore M
Histochem Cell Biol; 2010 Oct; 134(4):345-53. PubMed ID: 20811902
[TBL] [Abstract][Full Text] [Related]
17. CXCR2 Receptor: Regulation of Expression, Signal Transduction, and Involvement in Cancer.
Korbecki J; Kupnicka P; Chlubek M; Gorący J; Gutowska I; Baranowska-Bosiacka I
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216283
[TBL] [Abstract][Full Text] [Related]
18. Bronchial smooth muscle cells of asthmatics promote angiogenesis through elevated secretion of CXC-chemokines (ENA-78, GRO-α, and IL-8).
Keglowich L; Roth M; Philippova M; Resink T; Tjin G; Oliver B; Lardinois D; Dessus-Babus S; Gosens R; Hostettler Haack K; Tamm M; Borger P
PLoS One; 2013; 8(12):e81494. PubMed ID: 24339939
[TBL] [Abstract][Full Text] [Related]
19. Identification of IL-18 and Th17 cells in salivary glands of patients with Sjögren's syndrome, and amplification of IL-17-mediated secretion of inflammatory cytokines from salivary gland cells by IL-18.
Sakai A; Sugawara Y; Kuroishi T; Sasano T; Sugawara S
J Immunol; 2008 Aug; 181(4):2898-906. PubMed ID: 18684981
[TBL] [Abstract][Full Text] [Related]
20. The chemokine CXCL1/growth related oncogene increases sodium currents and neuronal excitability in small diameter sensory neurons.
Wang JG; Strong JA; Xie W; Yang RH; Coyle DE; Wick DM; Dorsey ED; Zhang JM
Mol Pain; 2008 Sep; 4():38. PubMed ID: 18816377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
